BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23438150)

  • 21. Association of Ki-67 antigen and p53 protein at invasive tumor front of oral squamous cell carcinoma.
    Verma R; Singh A; Jaiswal R; Chandra A; Verma R; Tak J
    Indian J Pathol Microbiol; 2014; 57(4):553-7. PubMed ID: 25308006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
    Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
    Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis.
    Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Okamune A; Sugiura S; Noguchi N; Yamamoto E
    J Oral Pathol Med; 2011 Oct; 40(9):693-8. PubMed ID: 21501231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
    Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
    Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of Gα12 predicts progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Cheng SJ; Liu YC; Cheng SL; Lee JJ; Chen HM; Chang HH; Kok SH; Kuo MY; Chiang CP
    J Oral Pathol Med; 2013 Aug; 42(7):565-9. PubMed ID: 23438080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteopontin Involves Cisplatin Resistance and Poor Prognosis in Oral Squamous Cell Carcinoma.
    Luo SD; Chen YJ; Liu CT; Rau KM; Chen YC; Tsai HT; Chen CH; Chiu TJ
    Biomed Res Int; 2015; 2015():508587. PubMed ID: 26491674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteopontin, a single marker for predicting the prognosis of patients with tumor-node-metastasis stage I hepatocellular carcinoma after surgical resection.
    Chen RX; Xia YH; Cui JF; Xue TC; Ye SL
    J Gastroenterol Hepatol; 2010 Aug; 25(8):1435-42. PubMed ID: 20659235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of osteopontin in esophageal squamous cell carcinoma: comparison with common tumor markers.
    Shimada Y; Watanabe G; Kawamura J; Soma T; Okabe M; Ito T; Inoue H; Kondo M; Mori Y; Tanaka E; Imamura M
    Oncology; 2005; 68(2-3):285-92. PubMed ID: 16015046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased expression of MCM5 is significantly associated with aggressive progression and poor prognosis of oral squamous cell carcinoma.
    Yu SY; Wang YP; Chang JY; Shen WR; Chen HM; Chiang CP
    J Oral Pathol Med; 2014 May; 43(5):344-9. PubMed ID: 24245508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of beta-2 adrenergic receptor in oral squamous cell carcinoma.
    Bravo-Calderón DM; Oliveira DT; Marana AN; Nonogaki S; Carvalho AL; Kowalski LP
    Cancer Biomark; 2011-2012; 10(1):51-9. PubMed ID: 22297552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma.
    Reichert TE; Scheuer C; Day R; Wagner W; Whiteside TL
    Cancer; 2001 Jun; 91(11):2136-47. PubMed ID: 11391595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan.
    Chen HH; Yu CH; Wang JT; Liu BY; Wang YP; Sun A; Tsai TC; Chiang CP
    Oral Oncol; 2007 Feb; 43(2):122-9. PubMed ID: 16798059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of Ki67 from clinically and histologically 'normal' distant mucosa in patients surgically treated for oral squamous cell carcinoma: a prospective study.
    Montebugnoli L; Badiali G; Marchetti C; Cervellati F; Farnedi A; Foschini MP
    Int J Oral Maxillofac Surg; 2009 Nov; 38(11):1165-72. PubMed ID: 19615859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Over-expression of osteopontin in non-small cell lung cancers: its clinical significance].
    Hu Z; Xiao T; Lin DM; Guo SP; Zhang ZQ; Di XB; Cheng SJ; Gao YN
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):591-5. PubMed ID: 18210878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of osteopontin expression in human gastric carcinoma.
    Higashiyama M; Ito T; Tanaka E; Shimada Y
    Ann Surg Oncol; 2007 Dec; 14(12):3419-27. PubMed ID: 17896150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of galectin-1 at the tumor invasion front is associated with poor prognosis in early-stage oral squamous cell carcinoma.
    Chiang WF; Liu SY; Fang LY; Lin CN; Wu MH; Chen YC; Chen YL; Jin YT
    Oral Oncol; 2008 Apr; 44(4):325-34. PubMed ID: 17588803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L; Wang Y; Xiao M; Lin Y; Yu L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck.
    Clauditz TS; Wang CJ; Gontarewicz A; Blessmann M; Tennstedt P; Borgmann K; Tribius S; Sauter G; Dalchow C; Knecht R; Münscher A; Wilczak W
    J Oral Pathol Med; 2013 Feb; 42(2):125-32. PubMed ID: 22643116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of osteopontin expression in T1 and T2 tongue cancers.
    Chien CY; Su CY; Chuang HC; Fang FM; Huang HY; Chen CM; Chen CH; Huang CC
    Head Neck; 2008 Jun; 30(6):776-81. PubMed ID: 18228527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The expression and significance of osteopontin and its receptor CD44v6 in oral squamous carcinoma].
    Jiang L; Zhao LY; He J; Zhao YF; Wu Y; Liu Y; Jiang XZ
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2008 Jun; 26(3):248-51. PubMed ID: 18705503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.